Over one thousand backers for ALS therapy developer

Posted on: Tuesday, August 20th, 2019

I reported previously (Mar 2017) on Israel’s NeuroSense, which is developing a treatment for amyotrophic lateral sclerosis (ALS). NeuroSense has just raised NIS 4 million from over 1,100 backers in a crowdfunding campaign.